Literatur
-
1 Hauner H, Buchholz G, Hamann A et al. Evidenzbasierte Leitlinie - Prävention und Therapie der Adipositas. Deutsche Adipositas-Gesellschaft, Deutsche Diabetes-Gesellschaft, Deutsche Gesellschaft für Ernährung, Deutsche Gesellschaft für Ernährungsmedizin (Hrsg.) 2007. www.adipositas-gesellschaft.de
-
2
Eckel R H, Grundy S M, Zimmet P Z.
The metabolic syndrome.
Lancet.
2005;
365
1415-1428
-
3
Blüher M, Stumvoll M.
Metabolic syndrome - myths, mechanisms, management.
Dtsch Med Wochenschr.
2006;
131
1167-1172
-
4
Hanefeld M, Leonhardt W.
Das metabolische Syndrom.
Dt Gesundheitswesen.
1981;
36
545-551
-
5
Mensink G B, Lampert T, Bergmann E.
Übergewicht und Adipositas in Deutschland 1984-2003.
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz.
2005;
48
1348-1356
-
6 Wirth A, Hauner H. Das Metabolische Syndrom. München: Urban & Vogel 2007
-
7
Grundy S M, Cleeman J I, Daniels S R et al.
American Heart Association; National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome: an American Heart Association / National Heart, Lung, and Blood Institute Scientific Statement.
Circulation.
2005;
112
2735-2752
-
8
Assmann G, Cullen P, Schulte H.
Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Munster (PROCAM) study.
Circulation.
2002;
105
310-315
-
9
Hebebrand J, Friedel S, Schäuble N et al.
Perspectives: molecular genetic research in human obesity.
Obes Rev.
2003;
4
139-146
-
10
Frayling T M, Timpson N J, Weedon M N et al.
A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity.
Science.
2007;
11: 316
889-894
-
11
Shen B J, Todaro J F, Niaura R et al.
Are metabolic risk factors one unified syndrome? Modeling the structure of the metabolic syndrome X.
Am J Epidemiol.
2003;
157
701-711
-
12
Klöting N, Stumvoll M, Blüher M.
The biology of visceral fat.
Internist.
2007;
48
126-133
-
13
Engeli S.
Role of the renin-angiotensin-aldosterone system in the metabolic syndrome.
Contrib Nephrol.
2006;
151
122-134
-
14
Tuomilehto J, Lindstrom J, Eriksson J G Finnish Diabetes Prevention Study Group et al.
Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance.
N Engl J Med.
2001;
344
1343-1350
-
15
Esposito K, Marfella R, Ciotola M et al.
Effect of a mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial.
JAMA.
2004;
92
1440-1446
-
16
Hamann A.
Pharmakotherapie der Adipositas.
Internist.
2008;
, (im Druck)
-
17
Hamann A, Morcos M, Nawroth P.
Diabetes mellitus Typ 2 - Medikamentöse Therapie.
CME.
2006;
3
11-20
-
18
UK Prospective Diabetes Study (UKPDS) Group .
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34).
Lancet.
1998;
352
854-865
-
19
Bosch J, Yusuf S, Gerstein H C et al.
Effect of ramipril on the incidence of diabetes.
N Engl J Med.
2006;
355
1551-1562
-
20
Sjöström L, Narbro K, Sjöström C D et al.
Swedish Obese Subjects Study. Effects of bariatric surgery on mortality in Swedish obese subjects.
N Engl J Med.
2007;
357
741-752
-
21 Fachkommission Diabetes in Sachsen .Praxisleitlinie Metabolisch-Vaskuläres Syndrom. Dresden 2006. www.imib.med.tu-dresden.de/diabetes
Prof. Dr. med. M. Blüher
Medizinische Klinik und Poliklinik III · Universität Leipzig
Philipp-Rosenthal-Straße 27
04103 Leipzig
Email: bluma@medizin.uni-leipzig.de
